UroViu Corporation

What UroViu Corporation does

UroViu Corporation is a privately held U.S. medical device company founded in 2016 and headquartered in Los Altos, California, that develops, manufactures, and commercializes single-use portable endoscopy platforms for cystoscopy and hysteroscopy procedures. The company's core offering centers on a modular architecture that pairs a reusable, battery-powered cordless handle (current generation UV5000; successor UV5000W with Wi-Fi connectivity; predecessor UV4500) with a suite of purpose-built disposable cannulas: the Uro-GHD HD cystoscope, Uro-G deflectable cystoscope, Uro-N injection cystoscope with integrated needle, Uro-V diagnostic cystoscope, and Hystero-V single-use hysteroscope. The platform incorporates a 1280x720 HD sensor, fully deflectable cannula designs with up to 340 degrees of range, and weighs roughly half to a third of comparable disposable products. The intellectual property portfolio covers more than 30 granted U.S. patents with additional filings pending, and the products carry FDA 510(k) clearances and CE certification. Manufacturing is vertically integrated with production facilities in Asia and operations in California and Washington.

The business model is built around per-procedure single-use consumable sales (disposable cannulas, graspers, biopsy forceps, and sterile drapes) supplemented by capital-equipment sales of the reusable handle. Pricing is quote-based rather than publicly disclosed, and the company positions the platform as eliminating capital outlay, reprocessing expenses, and annual service contracts versus traditional reusable cystoscopes. Go-to-market combines direct enterprise field sales, channel partnerships (UroGPO covering 700+ member urology practices; Fidelis Sustainability Distribution covering over 1,200 VA and DoD facilities via the Defense Logistics Agency ECAT contract), and international distributors enabled by CE marking. Customer segments span urology practices, urogynecology and gynecology clinics, VA and DoD healthcare facilities, ambulatory surgical centers, and academic medical centers, with named reference customers including Vanderbilt University Medical Center, Stanford University School of Medicine/VA Palo Alto, Manhattan Medical Research, and St. Luke's Hospital St. Louis. The company is led by founder and CEO Bruce OuYang, Ph.D., employs roughly 1-10 people per firmographics, and has not disclosed any external venture or growth funding rounds.

Name

UroViu Corporation

Legal name

UroViu Corporation

Website

https://uroviu.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

UroViu Corporation is a privately held medical device company that develops and commercializes a portable, cordless single-use endoscopy platform combining a reusable battery-powered handle with disposable cystoscope and hysteroscope cannulas, serving urology, urogynecology, gynecology, VA/DoD, and academic medical center customers.

Ownership category

akta.pro rank

Product category

Urological Endoscopy Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB)

akta.pro secondary industries

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA), Endourology & Minimally Invasive Urologic Surgery (HLAKAOAF), Minimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy) (HLAKAJAF), Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)

Keywords

• Single-use endoscopy
• Portable cystoscopy platform
• Disposable urological devices
• Single-use hysteroscopy
• Medical device manufacturing

Headquarters

HQ city

Los Altos

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Single-use Endoscope Cannulas: Disposable cystoscope and hysteroscope cannulas sold per procedure - the primary recurring revenue stream. Each procedure uses a new sterile single-use scope, creating a consumable/repeat purchase model.
2. Reusable Platform Handles: Reusable UV4500/UV5000 handles sold as capital equipment that are compatible with all single-use cannulas, graspers, and biopsy forceps
3. Accessories and Consumables: Single-use graspers, biopsy forceps, and sterile drapes sold as add-on consumables compatible with the platform

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Core offering

UroViu Corporation designs, manufactures, and commercializes a portable single-use endoscopy platform for cystoscopy and hysteroscopy procedures. The offering combines a reusable, battery-powered cordless handle with integrated LCD touchscreen and a suite of sterile, single-use disposable endoscope cannulas, along with compatible accessories such as graspers and biopsy forceps. The platform eliminates the need for capital equipment, reprocessing, and advance scheduling, transforming any clinical room into a procedure room.

Product overview

UroViu Corporation offers a modular single-use endoscopy platform comprising a reusable battery-powered cordless handle (UV5000/UV4500) and a suite of four purpose-designed single-use cannulas: Uro-GHD (16 Fr fully deflectable HD cystoscope), Uro-G (fully deflectable operative cystoscope), Uro-N (14 Fr injection cystoscope with integrated needle), and Uro-V (12 Fr diagnostic cystoscope), plus Hystero-V (12 Fr single-use hysteroscope). Accessories include single-use graspers and biopsy forceps. The platform is marketed under the 'Always Ready' branding for cystoscopy, urogynecology, and gynecology applications, providing HD visualization without capital equipment, reprocessing, or advance scheduling.

Differentiator

Problem solved

Functional benefit

Products and services

• UV5000 Platform Reusable, battery-powered cordless endoscopy handle and display unit serving as the core of the Always Ready platform. Features 5-inch 1024x768 touchscreen, 2-hour battery life, and weighs 362g. Compatible with all UroViu single-use cannulas, graspers, and biopsy forceps for cystoscopy and hysteroscopy.
• UV4500 Platform

Quantifiable outcome

• Comparable image quality, maneuverability, and patient experience to standard reusable cystoscopes (Stanford University study, 6 patients)
• +3 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered flagship and core.

• Asieris PharmaceuticalsflagshipStrategic or Co-development Partner · 18 May 2023Strategic collaboration granting Asieris exclusive global rights to utilize UroViu's patented portable single-use cystoscope technology for fluorescent imaging applications. Asieris leads research efforts and worldwide commercialization of sterile single-use fluorescent cystoscope for Non-Muscle Invasive Bladder Cancer (NMIBC) diagnosis and postoperative monitoring through cutting-edge non-white light imaging techniques.
• Fidelis Sustainability DistributioncoreChannel Partner/ Reseller/ Distributor · 13 October 2022Contract with Fidelis Sustainability Distribution facilitates distribution of UroViu's entire product range to over 1,200 VA and DoD healthcare facilities across the United States, serving approximately 9 million enrolled veterans annually through the Defense Logistics Agency Medical Equipment ECAT.
• UroGPOcoreChannel Partner/ Reseller/ Distributor · 2 June 2022UroViu became an Endoscopy Partner with UroGPO, making the Always Ready Cystoscopy platform available to UroGPO's 700+ member urology practices across the United States. UroViu provides preferential pricing for members, offering a cost-effective, single-use, and time-saving cystoscopy solution.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Ambu A/S: Ambu pioneered single-use flexible endoscopy with its aScope platform and is the most direct competitor to UroViu's single-use cystoscopy offering. Both companies sell sterile, disposable endoscopes intended to replace reusable capital equipment and eliminate reprocessing.
• Laborie Medical Technologies: Laborie specializes in urology and urogynecology diagnostic and therapeutic devices (urodynamics, cystoscopy, voiding dysfunction). It is a direct comp in the cystoscopy and urogyn call points and has acquired adjacent technologies (e.g., the former Cogentix Medical).

Broad incumbents

• Cook Medical: Cook Medical's urology division sells intermittent catheters, ureteral stents, and endoscopy accessories consumed in cystoscopy. Its single-use consumable focus and physician relationships make it a comp to UroViu's repeating-revenue model.
• Coloplast A/S: Coloplast is a major urology-focused medical device company with intermittent catheters, continence care, and reusable cystoscopy equipment. Its installed base and global sales network make it a comparable scaled incumbent in urology procedures.
• Boston Scientific Corporation: Boston Scientific operates one of the largest urology and pelvic health device businesses in the U.S. Its LithoVue single-use flexible ureteroscope is sold into the same urology call points as UroViu and validates the single-use category.
• Pentax Medical (HOYA): Pentax Medical, part of HOYA, sells reusable flexible endoscopes across GI, ENT, and urology. It competes with UroViu in endoscopy visualization, processing, and ergonomics, with broader portfolio scope.
• Olympus Corporation: Olympus is the global leader in reusable endoscopy with deep urology and gynecology portfolios. It is launching disposable/single-use options (e.g., EU-ME3, single-use bronchoscopes extended to cystoscopy) and is a credible competitive threat to UroViu's catheter-based platform.
• Stryker Corporation: Stryker's endoscopy division sells rigid and flexible visualization systems (Single-Use Solutions) and is increasingly entering adjacent procedure categories. It is comparable on visualization platform design and OR/cath-lab channel reach.
• Karl Storz SE & Co. KG: Karl Storz is the dominant incumbent in reusable flexible and rigid cystoscopy and hysteroscopy. It now offers single-use variants (e.g., the flexible cystoscope portfolio) and competes head-to-head with UroViu across urology and urogynecology channels.

Emerging players

• Asieris Pharmaceuticals: Asieris is a partner of UroViu and is commercializing UroViu's platform for fluorescent cystoscopy in NMIBC. Comparable as an emerging single-use urology player that leverages UroViu's IP for bladder-cancer-specific diagnostic indications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/uroviu
• Facebookfacebook.com/UroViuCorp
• LinkedInlinkedin.com/company/uroviu

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UroViu Corporation